Literature DB >> 23210664

Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.

Nick Van Boven1, Kjell Bogaard, Jaap Ruiter, Geert Kimman, Dominic Theuns, Isabella Kardys, Victor Umans.   

Abstract

INTRODUCTION: We evaluated clinical outcome and incidence of (in)appropriate shocks in consecutive chronic heart failure (CHF) patients treated with CRT with a defibrillator (CRT-D) according to functional response status. Furthermore, we investigated which factors predict such functional response. METHODS AND
RESULTS: In a large teaching hospital, 179 consecutive CHF patients received CRT-D in 2005-2010. Patients were considered functional responders if left ventricular ejection fraction (LVEF) increased to ≥ 35% postimplantation. Analysis was performed on 142 patients, who had CRT-D as primary prevention, complete data and a baseline LVEF <35%. Endpoints consisted of all-cause mortality, heart failure (HF) hospitalizations, appropriate shocks and inappropriate shocks. Median follow-up was 3.0 years (interquartile range [IQR] 1.6-4.4) and median baseline LVEF was 20% (IQR 18-25%). The functional response-group consisted of 42 patients. In this group no patients died, none were hospitalized for HF, none received appropriate shocks and 3 patients (7.1%) received ≥ 1 inappropriate shocks. In comparison, the functional nonresponse group consisted of 100 patients, of whom 22 (22%) died (P = 0.003), 17 (17%) were hospitalized for HF (P = 0.007), 17 (17%) had ≥ 1 appropriate shocks (P = 0.003) and 8 (8.1%) received ≥ 1 inappropriate shocks (P = 0.78). Multivariable analysis showed that left bundle branch block (LBBB), QRS duration ≥ 150 milliseconds and no need for diuretics at baseline are independent predictors of functional response.
CONCLUSION: Functional responders to CRT have a good prognosis and rarely need ICD therapy. LBBB, QRS duration ≥ 150 milliseconds and lack of chronic diuretic use predict functional response.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23210664     DOI: 10.1111/jce.12037

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  10 in total

1.  Impact of cardiac resynchronization therapy-defibrillator implantation on the association between body mass index and prognosis in patients with heart failure.

Authors:  Satoshi Yanagisawa; Yasuya Inden; Masayuki Shimano; Naoki Yoshida; Shinji Ishikawa; Hiroyuki Kato; Satoshi Okumura; Aya Miyoshi-Fujii; Tomoyuki Nagao; Toshihiko Yamamoto; Yoshiaki Mizutani; Tadahiro Ito; Makoto Hirai; Toyoaki Murohara
Journal:  J Interv Card Electrophysiol       Date:  2015-05-24       Impact factor: 1.900

2.  Predictors and long-term outcome of super-responders to cardiac resynchronization therapy.

Authors:  Abdul Ghani; Peter Paul H M Delnoy; Ahmet Adiyaman; Jan Paul Ottervanger; Anand R Ramdat Misier; Jaap Jan J Smit; Arif Elvan
Journal:  Clin Cardiol       Date:  2017-03-14       Impact factor: 2.882

Review 3.  When Is It Safe Not to Reimplant an Implantable Cardioverter Defibrillator at the Time of Battery Depletion?

Authors:  Sana M Al-Khatib; Daniel J Friedman; Gillian D Sanders
Journal:  Card Electrophysiol Clin       Date:  2018-03

4.  Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks.

Authors:  Jaber Abboud; Joachim R Ehrlich
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 5.  Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review.

Authors:  Neal A Chatterjee; Attila Roka; Steven A Lubitz; Michael R Gold; Claude Daubert; Cecilia Linde; Jan Steffel; Jagmeet P Singh; Theofanie Mela
Journal:  Eur Heart J       Date:  2015-08-10       Impact factor: 29.983

6.  Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function.

Authors:  Enrique Galve; Gerard Oristrell; Gabriel Acosta; Aida Ribera-Solé; Àngel Moya-Mitjans; Ignacio Ferreira-González; Jordi Pérez-Rodon; David García-Dorado
Journal:  Clin Cardiol       Date:  2018-06-05       Impact factor: 2.882

7.  Long-term outcome of patients with and without super-response to CRT-D.

Authors:  Jennifer Franke; Jeannette Keppler; Alamara Karimi Abadei; Amer Bajrovic; Lillian Meme; Christian Zugck; Philip W Raake; Edgar Zitron; Hugo A Katus; Lutz Frankenstein
Journal:  Clin Res Cardiol       Date:  2015-10-23       Impact factor: 5.460

8.  Development and Validation of Predictive Models of Cardiac Mortality and Transplantation in Resynchronization Therapy.

Authors:  Eduardo Arrais Rocha; Francisca Tatiana Moreira Pereira; José Sebastião Abreu; José Wellington O Lima; Marcelo de Paula Martins Monteiro; Almino Cavalcante Rocha Neto; Camilla Viana Arrais Goés; Ana Gardênia P Farias; Carlos Roberto Martins Rodrigues Sobrinho; Ana Rosa Pinto Quidute; Maurício Ibrahim Scanavacca
Journal:  Arq Bras Cardiol       Date:  2015-08-07       Impact factor: 2.000

9.  The risk of ventricular arrhythmias in a Dutch CRT population: CRT-defibrillator versus CRT-pacemaker.

Authors:  I A H Ter Horst; J van 't Sant; S C Wijers; M A Vos; M J Cramer; M Meine
Journal:  Neth Heart J       Date:  2016-03       Impact factor: 2.380

10.  Influence of the Right Ventricular Lead Location on Ventricular Arrhythmias in Cardiac Resynchronization Therapy.

Authors:  Hao Su; Pei Bao; Kang-Yu Chen; Ji Yan; Jian Xu; Fei Yu; Dong-Mei Yang
Journal:  Chin Med J (Engl)       Date:  2018-10-20       Impact factor: 2.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.